Showing 1 - 9 results of 9 for search 'Sigrid S Skånland', query time: 0.04s
Refine Results
-
1
Determining drug dose in the era of targeted therapies: playing it (un)safe? by Sigrid S. Skånland, Geir E. Tjønnfjord
Published 2022-08-01
Article -
2
SNX4 in complex with clathrin and dynein: implications for endosome movement. by Sigrid S Skånland, Sébastien Wälchli, Andreas Brech, Kirsten Sandvig
Published 2009-06-01
Article -
3
BiP Negatively Affects Ricin Transport by Kirsten Sandvig, Oddmund Bakke, Sigrid S. Skånland, Sébastien Wälchli, Tone F. Gregers
Published 2013-05-01
Article -
4
-
5
Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies by Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland
Published 2022-03-01
Article -
6
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine by Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland
Published 2023-04-01
Article -
7
P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES by Leonardo Miranda Santana, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Mariaserena Giliberto, Alexandra Gade, Arnoldo Frigessi, Geir E. Tjønnfjord, Ludvig A. Munthe, Sigrid S. Skånland, Manuela Zucknick, Kjetil Taskén
Published 2023-08-01
Article -
8
Standardized assays to monitor drug sensitivity in hematologic cancers by Pilar Ayuda-Durán, Johanne U. Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes, Sandra Gordon, Heikki Kuusanmäki, Andrea M. Brodersen, Aram N. Andersen, Kjetil Taskén, Krister Wennerberg, Jorrit M. Enserink, Sigrid S. Skånland
Published 2023-12-01
Article -
9
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines by Mariaserena Giliberto, Mariaserena Giliberto, Leonardo Miranda Santana, Leonardo Miranda Santana, Leonardo Miranda Santana, Toril Holien, Toril Holien, Toril Holien, Kristine Misund, Sigve Nakken, Sigve Nakken, Sigve Nakken, Daniel Vodak, Daniel Vodak, Daniel Vodak, Eivind Hovig, Eivind Hovig, Eivind Hovig, Leonardo A. Meza-Zepeda, Leonardo A. Meza-Zepeda, Leonardo A. Meza-Zepeda, Eivind Coward, Eivind Coward, Anders Waage, Anders Waage, Anders Waage, Kjetil Taskén, Kjetil Taskén, Sigrid S. Skånland, Sigrid S. Skånland
Published 2022-11-01
Article